nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0703	0.0703	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0598	0.0598	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0568	0.0568	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0528	0.0528	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0453	0.0453	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0449	0.0449	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0427	0.0427	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GABRA2—conduct disorder	0.0405	0.0405	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0381	0.0381	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GABRA2—conduct disorder	0.0344	0.0344	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.0327	0.0327	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0295	0.0295	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—COMT—conduct disorder	0.0254	0.0254	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0253	0.0253	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0248	0.0248	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.0216	0.0216	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0215	0.0215	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0204	0.0204	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0201	0.0201	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—COMT—conduct disorder	0.0195	0.0195	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0194	0.0194	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—MAOA—conduct disorder	0.0194	0.0194	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—COMT—conduct disorder	0.0166	0.0166	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—MAOA—conduct disorder	0.0165	0.0165	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—COMT—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—MAOA—conduct disorder	0.0156	0.0156	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0139	0.0139	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00941	0.00941	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00874	0.00874	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00853	0.00853	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00749	0.00749	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00575	0.00575	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00522	0.00522	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00488	0.00488	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00452	0.00452	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00372	0.00372	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.0021	0.0021	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00191	0.00191	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000597	0.000597	CbGpPWpGaD
